Page 2 - Hqy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hqy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HealthEquity (NASDAQ:HQY – Get Free Report) had its price objective lifted by JPMorgan Chase & Co. from $86.00 to $108.00 in a report released on Tuesday, Briefing.com reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 31.39% from the company’s previous close. […] ....
HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) CEO Jon Kessler sold 33,765 shares of HealthEquity stock in a transaction on Friday, March 22nd. The shares were sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the transaction, the chief executive officer now owns 126,635 shares in the company, valued at […] ....
Barrington Research reissued their outperform rating on shares of HealthEquity (NASDAQ:HQY – Free Report) in a research report sent to investors on Friday, Benzinga reports. They currently have a $100.00 price target on the stock. A number of other research firms have also weighed in on HQY. Bank of America raised their price target on […] ....
HealthEquity (NASDAQ:HQY – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share guidance of 2.200-2.240 for the period, compared to the consensus earnings per share estimate of 2.140. The company issued revenue guidance of $995.0 million-$1.0 billion, compared to the consensus revenue estimate of $992.7 million. HealthEquity […] ....
HealthEquity (NASDAQ:HQY – Get Free Report) had its target price boosted by equities researchers at Royal Bank of Canada from $77.00 to $90.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective would indicate a […] ....